Literature DB >> 6342139

"Good risk" non-Hodgkin lymphomas: approaches to management.

C S Portlock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342139

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  3 in total

1.  A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.

Authors:  J Skillings; C Cripps; E Eisenhauer; J Pater; S Verma; D Walde
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

2.  Pathology: lymphoma-correlating morphology and clinical course of disease.

Authors:  A M Levine
Journal:  West J Med       Date:  1986-09

3.  Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.

Authors:  T Chisesi; G Capnist; M Vespignani; G Cetto
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.